No Data
No Data
Ladenburg Thalmann Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $30
Buy Rating for Achieve Life Sciences on Cytisinicline's Promise in Nicotine Addiction Treatment
Express News | Achieve Life Sciences Announces FDA Granted Breakthrough Therapy Designation For Cytisinicline
Express News | Achieve Life Sciences Inc - Plans End-of-Phase 2 Meeting With FDA
Express News | Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence
Achieve Life Sciences Shares Fall After Securing $20 Million Debt Refinancing Deal
No Data